Navigating the Biomarker Landscape in Still's Disease and Macrophage Activation Syndrome: Toward Precision Diagnosis
I-Chang Lai1, Chen-Ching Wu2, Pei-Fen Liao3,4
1Department of Education, China Medical University Hospital, China Medical University, Taichung, Taiwan.
International Journal of Rheumatic Diseases
|May 4, 2026
Abstract
No abstract available in PubMed .
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Inflammatory Bowel Disease IV: Pharmacological Management
1.1K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
1.1K

